Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity

Michael R. Folkert, Samuel Singer, Murray F. Brennan, Deborah Kuk, Li Xuan Qin, Wendy K. Kobayashi, Aimee M. Crago, Kaled M. Alektiar

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Purpose: The use of intensity-modulated radiation therapy (IMRT) in the treatment of soft tissue sarcoma (STS) of the extremity is increasing, but no large-scale direct comparison has been reported between conventional external-beam radiation therapy (EBRT) and IMRT.

Results: Treatment groups were comparable in terms of tumor location, histology, tumor size, depth, and use of chemotherapy. Patients treated with IMRT were older (P =.08), had more high-grade lesions (P =.05), close (< 1 mm) or positive margins (P =.04), preoperative radiation (P <.001), and nerve manipulation (P =.04). Median follow-up was 90 months for patients treated with conventional EBRT and 42 months for patients treated with IMRT. On multivariable analysis adjusting for patient age and tumor size, IMRT retained significance as an independent predictor of reduced LR (hazard ratio = 0.46; 95% CI, 0.24 to 0.89; P =.02)

Methods: Between January 1996 and December 2010, 319 consecutive adult patients with primary nonmetastatic extremity STS were treated with limb-sparing surgery and adjuvant radiotherapy (RT) at a single institution. Conventional EBRT was used in 154 patients and IMRT in 165 with similar dosing schedules. Median follow-up time for the cohort was 58 months.

Conclusion: Despite a preponderance of higher-risk features (especially close/positive margin) in the IMRT group, IMRT was associated with significantly reduced local recurrence compared with conventional EBRT for primary STS of the extremity.

Original languageEnglish (US)
Pages (from-to)3236-3241
Number of pages6
JournalJournal of Clinical Oncology
Volume32
Issue number29
DOIs
StatePublished - Oct 10 2014

Fingerprint

Sarcoma
Radiotherapy
Extremities
Recurrence
Neoplasms
Adjuvant Radiotherapy
Histology
Appointments and Schedules
Radiation
Drug Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. / Folkert, Michael R.; Singer, Samuel; Brennan, Murray F.; Kuk, Deborah; Qin, Li Xuan; Kobayashi, Wendy K.; Crago, Aimee M.; Alektiar, Kaled M.

In: Journal of Clinical Oncology, Vol. 32, No. 29, 10.10.2014, p. 3236-3241.

Research output: Contribution to journalArticle

Folkert, Michael R. ; Singer, Samuel ; Brennan, Murray F. ; Kuk, Deborah ; Qin, Li Xuan ; Kobayashi, Wendy K. ; Crago, Aimee M. ; Alektiar, Kaled M. / Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. In: Journal of Clinical Oncology. 2014 ; Vol. 32, No. 29. pp. 3236-3241.
@article{bb0e68e4f77f42778755d3db5f89337c,
title = "Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity",
abstract = "Purpose: The use of intensity-modulated radiation therapy (IMRT) in the treatment of soft tissue sarcoma (STS) of the extremity is increasing, but no large-scale direct comparison has been reported between conventional external-beam radiation therapy (EBRT) and IMRT.Results: Treatment groups were comparable in terms of tumor location, histology, tumor size, depth, and use of chemotherapy. Patients treated with IMRT were older (P =.08), had more high-grade lesions (P =.05), close (< 1 mm) or positive margins (P =.04), preoperative radiation (P <.001), and nerve manipulation (P =.04). Median follow-up was 90 months for patients treated with conventional EBRT and 42 months for patients treated with IMRT. On multivariable analysis adjusting for patient age and tumor size, IMRT retained significance as an independent predictor of reduced LR (hazard ratio = 0.46; 95{\%} CI, 0.24 to 0.89; P =.02)Methods: Between January 1996 and December 2010, 319 consecutive adult patients with primary nonmetastatic extremity STS were treated with limb-sparing surgery and adjuvant radiotherapy (RT) at a single institution. Conventional EBRT was used in 154 patients and IMRT in 165 with similar dosing schedules. Median follow-up time for the cohort was 58 months.Conclusion: Despite a preponderance of higher-risk features (especially close/positive margin) in the IMRT group, IMRT was associated with significantly reduced local recurrence compared with conventional EBRT for primary STS of the extremity.",
author = "Folkert, {Michael R.} and Samuel Singer and Brennan, {Murray F.} and Deborah Kuk and Qin, {Li Xuan} and Kobayashi, {Wendy K.} and Crago, {Aimee M.} and Alektiar, {Kaled M.}",
year = "2014",
month = "10",
day = "10",
doi = "10.1200/JCO.2013.53.9452",
language = "English (US)",
volume = "32",
pages = "3236--3241",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "29",

}

TY - JOUR

T1 - Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity

AU - Folkert, Michael R.

AU - Singer, Samuel

AU - Brennan, Murray F.

AU - Kuk, Deborah

AU - Qin, Li Xuan

AU - Kobayashi, Wendy K.

AU - Crago, Aimee M.

AU - Alektiar, Kaled M.

PY - 2014/10/10

Y1 - 2014/10/10

N2 - Purpose: The use of intensity-modulated radiation therapy (IMRT) in the treatment of soft tissue sarcoma (STS) of the extremity is increasing, but no large-scale direct comparison has been reported between conventional external-beam radiation therapy (EBRT) and IMRT.Results: Treatment groups were comparable in terms of tumor location, histology, tumor size, depth, and use of chemotherapy. Patients treated with IMRT were older (P =.08), had more high-grade lesions (P =.05), close (< 1 mm) or positive margins (P =.04), preoperative radiation (P <.001), and nerve manipulation (P =.04). Median follow-up was 90 months for patients treated with conventional EBRT and 42 months for patients treated with IMRT. On multivariable analysis adjusting for patient age and tumor size, IMRT retained significance as an independent predictor of reduced LR (hazard ratio = 0.46; 95% CI, 0.24 to 0.89; P =.02)Methods: Between January 1996 and December 2010, 319 consecutive adult patients with primary nonmetastatic extremity STS were treated with limb-sparing surgery and adjuvant radiotherapy (RT) at a single institution. Conventional EBRT was used in 154 patients and IMRT in 165 with similar dosing schedules. Median follow-up time for the cohort was 58 months.Conclusion: Despite a preponderance of higher-risk features (especially close/positive margin) in the IMRT group, IMRT was associated with significantly reduced local recurrence compared with conventional EBRT for primary STS of the extremity.

AB - Purpose: The use of intensity-modulated radiation therapy (IMRT) in the treatment of soft tissue sarcoma (STS) of the extremity is increasing, but no large-scale direct comparison has been reported between conventional external-beam radiation therapy (EBRT) and IMRT.Results: Treatment groups were comparable in terms of tumor location, histology, tumor size, depth, and use of chemotherapy. Patients treated with IMRT were older (P =.08), had more high-grade lesions (P =.05), close (< 1 mm) or positive margins (P =.04), preoperative radiation (P <.001), and nerve manipulation (P =.04). Median follow-up was 90 months for patients treated with conventional EBRT and 42 months for patients treated with IMRT. On multivariable analysis adjusting for patient age and tumor size, IMRT retained significance as an independent predictor of reduced LR (hazard ratio = 0.46; 95% CI, 0.24 to 0.89; P =.02)Methods: Between January 1996 and December 2010, 319 consecutive adult patients with primary nonmetastatic extremity STS were treated with limb-sparing surgery and adjuvant radiotherapy (RT) at a single institution. Conventional EBRT was used in 154 patients and IMRT in 165 with similar dosing schedules. Median follow-up time for the cohort was 58 months.Conclusion: Despite a preponderance of higher-risk features (especially close/positive margin) in the IMRT group, IMRT was associated with significantly reduced local recurrence compared with conventional EBRT for primary STS of the extremity.

UR - http://www.scopus.com/inward/record.url?scp=84907482309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907482309&partnerID=8YFLogxK

U2 - 10.1200/JCO.2013.53.9452

DO - 10.1200/JCO.2013.53.9452

M3 - Article

VL - 32

SP - 3236

EP - 3241

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 29

ER -